CB Innovations, LLC

CB Innovations (trading as C-Booth Innovations) manufactures the EXG™ wearable ECG platform, an advanced 12-lead continuous cardiac monitoring system designed for rapid deployment in emergency medical services, hospitals, and catheterization labs. Founded by two practicing emergency physicians with over 30 years of combined clinical experience, the company addresses critical gaps in current ECG workflows: electrode misapplication (94.2% rate), diagnostic delays (29% of STEMI patients lack ECG within 10 minutes), and false positives (72% of unnecessary cath lab activations). The EXG™ system enables setup in under 60 seconds with a single connection point, AHA-compliant electrode placement, motion artifact reduction, and expandable 18-lead capability for right-sided and posterior visualization. The platform supports continuous monitoring during imaging, stress testing, and post-ROSC resuscitation, with universal monitor compatibility and seamless EMS-to-ED handoff protocols. FDA-registered and ISO-certified, the device addresses the 2 cm electrode misplacement problem that can obscure ST-segment changes and hide myocardial infarctions.